Pharma Mar SA (PMRA.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
At close: 09:50PM CEST
| Previous close | 32.72 |
| Open | 32.82 |
| Bid | 31.34 x N/A |
| Ask | 32.38 x N/A |
| Day's range | 31.80 - 32.82 |
| 52-week range | 26.14 - 43.80 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
PharmaMar presents encouraging results at ASCO for Small Cell Lung Cancer
PharmaMar (MSE: PHM), world leader in the discovery, development and commercialization of marine-derived cancer treatments, presented data from a Phase II trial evaluating PharmaMar's lurbinectedin in combination with irinotecan in patients with relapsed Small Cell Lung Cancer (SCLC) after prior platinum-based treatment at the American Society of Clinical Oncology (ASCO) meeting, which took place from 31st May to 4th June in Chicago, United States.
© 2024 Yahoo. All rights reserved.